Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.

Ritz E, Laville M, Bilous RW, O'Donoghue D, Scherhag A, Burger U, de Alvaro F; Anemia Correction in Diabetes Study Investigators.

Am J Kidney Dis. 2007 Feb;49(2):194-207. Erratum in: Am J Kidney Dis. 2007 Apr;49(4):562.

PMID:
17261422
2.

Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD.

Levin A, Djurdjev O, Thompson C, Barrett B, Ethier J, Carlisle E, Barre P, Magner P, Muirhead N, Tobe S, Tam P, Wadgymar JA, Kappel J, Holland D, Pichette V, Shoker A, Soltys G, Verrelli M, Singer J.

Am J Kidney Dis. 2005 Nov;46(5):799-811.

PMID:
16253719
3.

Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A; CREATE Investigators.

N Engl J Med. 2006 Nov 16;355(20):2071-84.

4.
5.

New strategies in anaemia management: ACORD (Anaemia CORrection in Diabetes) trial.

Laville M; Anaemia CORrection in Diabetes trial.

Acta Diabetol. 2004 Mar;41 Suppl 1:S18-22.

PMID:
15103544
6.

Effect of anemia correction on left ventricular hypertrophy in patients with modestly high hemoglobin level and chronic kidney disease .

Akaishi M, Hiroe M, Hada Y, Suzuki M, Tsubakihara Y, Akizawa T; KRN321 Study Group.

J Cardiol. 2013 Oct;62(4):249-56. doi: 10.1016/j.jjcc.2013.04.008. Epub 2013 Jun 18.

7.

Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients.

Hirakata H, Tsubakihara Y, Gejyo F, Nishi S, Iino Y, Watanabe Y, Suzuki M, Saito A, Akiba T, Inaguma D, Fukuhara S, Morita S, Hiroe M, Hada Y, Suzuki M, Akaishi M, Aonuma K, Akizawa T.

Clin Exp Nephrol. 2010 Feb;14(1):28-35. doi: 10.1007/s10157-009-0212-4. Epub 2009 Sep 9.

PMID:
19763743
8.

Italian randomized trial of hemoglobin maintenance to prevent or delay left ventricular hypertrophy in chronic kidney disease.

Cianciaruso B, Ravani P, Barrett BJ, Levin A; ITA-EPO-7 investigators.

J Nephrol. 2008 Nov-Dec;21(6):861-70.

PMID:
19034870
9.

Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis.

Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P.

Clin J Am Soc Nephrol. 2009 Apr;4(4):755-62. doi: 10.2215/CJN.02730608. Epub 2009 Apr 1. Review.

10.
11.

Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial.

Villar E, Lièvre M, Kessler M, Lemaître V, Alamartine E, Rodier M, François M, Zaoui P, Moranne O, Choukroun G, Guerraoui A, Jolivot A, Janin G, Branger B, Heng AE, Boudray C, Bissery A, Rabilloud M, Pouteil-Noble C.

J Diabetes Complications. 2011 Jul-Aug;25(4):237-43. doi: 10.1016/j.jdiacomp.2011.03.003. Epub 2011 May 20.

PMID:
21601481
12.

[Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].

Stojimirović B, Petrović D, Obrenović R.

Med Pregl. 2007;60 Suppl 2:155-9. Serbian.

PMID:
18928184
13.

Predictors of congestive heart failure in patients on maintenance hemodialysis.

Ito S, Murai S, Sugiura M, Yoshida T, Fukutomi T.

Circ J. 2007 Sep;71(9):1424-9.

14.

Regression of left ventricular hypertrophy in hemodialysis patients is possible.

Hampl H, Sternberg C, Berweck S, Lange D, Lorenz F, Pohle C, Riedel E, Gogoll L, Hennig L.

Clin Nephrol. 2002 Jul;58 Suppl 1:S73-96.

PMID:
12227731
15.
16.

Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial.

Roger SD, McMahon LP, Clarkson A, Disney A, Harris D, Hawley C, Healy H, Kerr P, Lynn K, Parnham A, Pascoe R, Voss D, Walker R, Levin A.

J Am Soc Nephrol. 2004 Jan;15(1):148-56.

17.

The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.

Singh NP, Chandrashekhar, Nair M, Anuradha S, Kohli R, Agarwal SK.

J Assoc Physicians India. 2000 Mar;48(3):301-6.

PMID:
11229114
18.

Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation.

Covic A, Mardare NG, Ardeleanu S, Prisada O, Gusbeth-Tatomir P, Goldsmith DJ.

J Nephrol. 2006 Nov-Dec;19(6):783-93.

PMID:
17173253
19.

Effect of early correction of anemia on the progression of CKD.

Rossert J, Levin A, Roger SD, Hörl WH, Fouqueray B, Gassmann-Mayer C, Frei D, McClellan WM.

Am J Kidney Dis. 2006 May;47(5):738-50.

PMID:
16632012
20.

Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia.

Berweck S, Hennig L, Sternberg C, Dingerkus H, Ludat K, Hampl H.

Clin Nephrol. 2000 Feb;53(1 Suppl):S80-5.

PMID:
10746811
Items per page

Supplemental Content

Write to the Help Desk